<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/elvn" ></link>
<id>urn:uuid:42be4a58-966d-1580-38fc-1872d4cb779f</id>
<updated>2026-08-02T23:38:19-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ELVN: HOHL BENJAMIN (CFO) Exercised 1,072 Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 7/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6443785" ></link>
<id>urn:uuid:d513adcf-68ca-9910-20c0-29d738c10015</id>
<updated>2026-07-21T17:24:30-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.81. Mkt Cap:3.9B. 10D Vol: 698,860]]></summary>
</entry>
<entry>
<title>ELVN: COLLINS HELEN LOUISE (O) Exercised 5k Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 7/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6443783" ></link>
<id>urn:uuid:acf55911-4d7f-3a11-5287-d46ac18a0dee</id>
<updated>2026-07-21T17:23:03-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.81. Mkt Cap:3.9B. 10D Vol: 698,860]]></summary>
</entry>
<entry>
<title>ELVN: KUNKEL LORI ANNE (DIR) Sold (AS) 10k Shares of ENLIVEN THERAPEUTICS INC for $49.98-$50.84 on 7/6</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6439693" ></link>
<id>urn:uuid:19a16795-61cc-50c2-8298-117151029f41</id>
<updated>2026-07-08T17:15:48-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.81. Mkt Cap:3.9B. 10D Vol: 698,860]]></summary>
</entry>
<entry>
<title>ELVN: ORBIMED ADVISORS LLC (BO) Sold (JS*) 48,253 Shares of ENLIVEN THERAPEUTICS INC for $45.00 on 6/22</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6432101" ></link>
<id>urn:uuid:53d73089-6bfe-025f-5824-2b300f8fab6b</id>
<updated>2026-06-24T19:19:54-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.81. Mkt Cap:3.9B. 10D Vol: 698,860]]></summary>
</entry>
<entry>
<title>ELVN: ORBIMED ADVISORS LLC (BO) Sold (S) 811,870 Shares of ENLIVEN THERAPEUTICS INC for $45.38 on 6/22</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6432102" ></link>
<id>urn:uuid:f2f44f62-9740-96f1-3374-d4090bfb6fff</id>
<updated>2026-06-24T19:19:54-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.81. Mkt Cap:3.9B. 10D Vol: 698,860]]></summary>
</entry>
<entry>
<title>ELVN: HOHL BENJAMIN (CFO) Exercised 6,018 Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 6/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6430650" ></link>
<id>urn:uuid:00589a8f-1fda-6259-44c6-5f8d60ec222f</id>
<updated>2026-06-22T17:13:12-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.81. Mkt Cap:3.9B. 10D Vol: 698,860]]></summary>
</entry>
</feed>